667, L.P., Director at Neoleukin Therapeutics, Inc. (NLTX), bought 3,267,579 shares at $8.40 ($27.4M) on 2019-12-20, disclosed to the SEC on 2019-12-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.40 | 250,037 | $2.1M | 7.7% |
| 2 | $8.40 | 250,037 | $2.1M | 7.7% |
| 3 | $8.40 | 2,767,505 | $23.2M | 84.7% |
| Total | $8.40 avg | 3,267,579 | $27.4M | 100% |
| Filing → |
| MDGL | BUY | 2023-12-14 | $14.7M | — | Filing → |
| ACAD | BUY | 2023-05-24 | $45.4M | — | Filing → |
| TCRX | BUY | 2022-05-12 | $4.8M | — | Filing → |